Evidence map›Paper›PMID 21772035›Full record

ReviewJournal of immunology (Baltimore, Md. : 1950)2011

NKT cell ligand recognition logic: molecular basis for a synaptic duet and transmission of inflammatory effectors.

Sebastian Joyce, Enrico Girardi, Dirk M Zajonc

Abstract readReview
In one paragraph

Review in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Trial
  2. Frontiers in immunology · 2025
    Article
  3. Review
  4. Article
  5. Frontiers in immunology · 2023
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. The CD1 size problem: lipid antigens, ligands, and scaffolds.Cellular and molecular life sciences : CMLS · 2014
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sebastian JoyceDepartment of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. sebastian.joyce@vanderbilt.edu
Enrico Girardi
Dirk M Zajonc

Funding

MOLECULAR BASIS OF CDLDL AND NATURAL T CELL FUNCTIONR01AI042284 · NIAID · VANDERBILT UNIVERSITY · PI JOYCE, SEBASTIAN · 1998 to 2013
$3.1M
INTERLEUKIN 2 IMMUNOTHERAPY FOR HCV INFECTIONU01AI048224 · NIAID · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI SMITH, KENDALL A · 2000 to 2004
$2.2M
Molecular Basis of iNKT Cell Ontogeny and FunctionR01AI061721 · NIAID · VANDERBILT UNIVERSITY · PI JOYCE, SEBASTIAN · 2006 to 2010
$2.1M
Structural Immunology of CD1 and CD1-TCR ComplexesR01AI074952 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI ZAJONC, DIRK M · 2009 to 2013
$1.8M
Processing and Presentation of Minor Histocompatibility Antigens that Cause GvHDR01HL121139 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI JOYCE, SEBASTIAN · 2014 to 2017
$1.6M
Structural Immunology of CD1 and CD1-TCR ComplexesR56AI074952 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI ZAJONC, DIRK M · 2008 to 2008
$412k
NHLBI NIH HHS R01 HL121139NIAID NIH HHS AI048224NIAID NIH HHS AI061721NIAID NIH HHS AI074952NIAID NIH HHS R01 AI042284NIAID NIH HHS R01 AI061721NIAID NIH HHS R01 AI074952NIAID NIH HHS R56 AI074952NIAID NIH HHS U01 AI048224
6 · The paper itself

Abstract

NKT cells that express the semi-invariant TCR are innate-like lymphocytes whose functions are regulated by self and foreign glycolipid ligands presented by the Ag-presenting, MHC class I-like molecule CD1d. Activation of NKT cells in vivo results in rapid release of copious amounts of effector cytokines and chemokines with which they regulate innate and adaptive immune responses to pathogens, certain types of cancers, and self-antigens. The nature of CD1d-restricted ligands, the manner in which they are recognized, and the unique effector functions of NKT cells suggest an immunoregulatory role for this T cell subset. Their ability to respond fast and our ability to steer NKT cell cytokine response to altered lipid ligands make them an important target for vaccine design and immunotherapies against autoimmune diseases. This review summarizes our current understanding of CD1d-restricted ligand recognition by NKT cells and how these innate-like lymphocytes regulate inflammation.

Indexed as

AnimalsAntigen PresentationGalactosylceramidesGlycolipidsHumansImmunological SynapsesInflammationInflammation MediatorsLigandsLipid MetabolismNatural Killer T-Cellsalpha-galactosylceramideGalactosylceramidesGlycolipidsInflammation MediatorsLigands

Identifiers

PMID21772035
PMCPMC3166221

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.